Year: 2010

CFTC Chairman Gary Gensler has become one of the leading proponents for the regulation of OTC derivatives. In his remarks to the Council of Institutional Investors on April 13, 2010, Mr. Gensler outlined what he views as the key provisions …

CFTC CHAIRMAN GENSLER ON OTC DERIVATIVES Read More »

The Second Circuit reaffirmed the basic principle that in a Section 10(b) fraud case predicated on omissions there must be a duty before the person has an obligations to disclose the facts. Vladimir v. Bioenvision, Inc., Case No. 09-3487–cv (2nd …

SECOND CIRCUIT DISMISSES FRAUD COMPLAINT BASED ON OMISSIONS Read More »